MA28462B1 - Formulations pour inhalation - Google Patents

Formulations pour inhalation

Info

Publication number
MA28462B1
MA28462B1 MA29312A MA29312A MA28462B1 MA 28462 B1 MA28462 B1 MA 28462B1 MA 29312 A MA29312 A MA 29312A MA 29312 A MA29312 A MA 29312A MA 28462 B1 MA28462 B1 MA 28462B1
Authority
MA
Morocco
Prior art keywords
inhalation
formulations
Prior art date
Application number
MA29312A
Other languages
English (en)
Inventor
Amar Lulla
Geena Malhotra
Original Assignee
Cipla Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cipla Ltd filed Critical Cipla Ltd
Publication of MA28462B1 publication Critical patent/MA28462B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
MA29312A 2004-03-12 2006-09-08 Formulations pour inhalation MA28462B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN312MU2004 2004-03-12

Publications (1)

Publication Number Publication Date
MA28462B1 true MA28462B1 (fr) 2007-03-01

Family

ID=34962995

Family Applications (1)

Application Number Title Priority Date Filing Date
MA29312A MA28462B1 (fr) 2004-03-12 2006-09-08 Formulations pour inhalation

Country Status (9)

Country Link
EP (1) EP1732526A2 (fr)
JP (1) JP2007528889A (fr)
KR (1) KR20060135873A (fr)
AP (1) AP2006003734A0 (fr)
IL (1) IL177596A0 (fr)
MA (1) MA28462B1 (fr)
RU (1) RU2006136025A (fr)
WO (1) WO2005087192A2 (fr)
ZA (1) ZA200606801B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016052897A1 (fr) * 2014-09-30 2016-04-07 Hanmi Pharm. Co., Ltd. Poudre sèche pour formulation d'inhalation ayant une stabilité améliorée de principes actifs combinés

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZW6584A1 (en) * 1983-04-18 1985-04-17 Glaxo Group Ltd Phenethanolamine derivatives
IL95590A (en) * 1989-09-08 1996-06-18 Glaxo Group Ltd Medicinal preparations containing Salmetrol and Pluticasone Propionate
GB2235627B (en) * 1989-09-08 1993-09-01 Glaxo Group Ltd Inhalation medicaments for treating respiratory disorders
TR199701169T1 (xx) * 1995-04-14 1998-03-21 Glaxo Wellcome Inc. Salmeterol i�in �l��lm�� doz inhaleri.
GB9808802D0 (en) * 1998-04-24 1998-06-24 Glaxo Group Ltd Pharmaceutical formulations
US6919325B2 (en) * 2001-09-14 2005-07-19 Boehringer Ingelheim Pharma Kg Pharmaceutical compositions containing tiotropium salts and low-solubility salmeterol salts
WO2004019985A1 (fr) * 2002-08-29 2004-03-11 Cipla Ltd Produits et compositions pharmaceutiques comprenant des agents anticholinergiques specifiques, des agonistes beta-2 et des corticosteroides

Also Published As

Publication number Publication date
RU2006136025A (ru) 2008-04-20
JP2007528889A (ja) 2007-10-18
ZA200606801B (en) 2008-05-28
AP2006003734A0 (en) 2006-10-31
WO2005087192A3 (fr) 2006-06-15
IL177596A0 (en) 2006-12-10
EP1732526A2 (fr) 2006-12-20
WO2005087192A2 (fr) 2005-09-22
KR20060135873A (ko) 2006-12-29

Similar Documents

Publication Publication Date Title
HUS1800003I1 (hu) Fungicid kompozíciók
DK1812025T3 (da) Stabiliserede bakteriofagformuleringer
IL237756A0 (en) Antibody compositions
BRPI0511900A (pt) composições farmacêuticas
DE602005010938D1 (de) Genauguss
DE602005020680D1 (de) Mikrobizide Zusammensetzung
DK1750683T3 (da) Formuleringer med langvarig frigivelse
DK1725218T3 (da) Farmaceutisk sammensætning omfattende pimobendan
DE502004010641D1 (de) Atemschutzmaske
ITMI20042238A1 (it) Composti per fluoropolirterei
DK1740484T3 (da) Platform
EP1865805A4 (fr) Pochette detachable
DE202005000407U1 (de) Arbeitsbühne
GB0423800D0 (en) New pharmaceutical formulations
ITMI20041447A1 (it) Composizione farmaceutica comprendente gabapentina
ITMI20040943A1 (it) Composizione farmaceutica cicatrizzante
MA28462B1 (fr) Formulations pour inhalation
NO20042027D0 (no) Oral composition
AT501354A3 (de) Atemmaske
FR2872407B1 (fr) Corset pour lombalgie
ATE384719T1 (de) Dioxazinyl-substituierte thienylsulfonylaminocarbonylverbindungen
IL179208A0 (en) Intereferon formulations
FR2879491B1 (fr) Ciseaux pour enfants
UA11878S (uk) Інгалятор
NO20043762D0 (no) Fôr